Astellas Pharma Inc (ALPMF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astellas Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.714 Thank you very much for joining this 00:00:03.918 -- 00:00:05.918 Q2YTD 00:00:06.101 -- 00:00:07.964 FY2025 00:00:07.964 -- 00:00:11.106 Earnings Call by ASTELUS. 00:00:13.013 -- 00:00:16.178 I would like to serve as a moderator for today. 00:00:16.178 -- 00:00:17.981 I'm 00:00:17.981 -- 00:00:23.953 Chief Communications and IR Officer Kato. Thank you for this 00:00:23.953 -- 00:00:29.323 opportunity. Today, first of all, we would like to give you the presentation, and 00:00:29.323 -- 00:00:33.971 after that, we'll have Q&A session. On 00:00:33.971 -- 00:00:38.980 our website, presentation material is available, and in line with that, we are going 00:00:38.980 -- 00:00:40.987 to make a presentation. 00:00:40.987 -- 00:00:45.999 Including Q&A, we will provide you the simultaneous 00:00:45.999 -- 00:00:49.347 interpretation service between Japanese and English. 00:00:49.347 -- 00:00:54.079 For simultaneous interpretation service, we are not going to guarantee the accuracy of 00:00:54.079 -- 00:00:59.321 it. When it comes to the language for this meeting, you can select 00:00:59.321 -- 00:01:02.002 it from the 00:01:02.246 -- 00:01:07.254 Zoom webinar screen. And if you select the original, then you can listen to the 00:01:07.254 -- 00:01:13.083 original voices without hearing the interpretation voices. 00:01:13.083 -- 00:01:18.191 These are some notes. This material or a presentation by representatives for the 00:01:18.191 -- 00:01:23.098 company and answers and statements by representatives for the company in the QA session 00:01:23.098 -- 00:01:28.125 includes forelooking statements based on assumptions and beliefs in light of the information 00:01:28.125 -- 00:01:33.413 currently available to management as subject to significant r...